GGT7

Across TCGA pan-cancer cohorts, GGT7 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated GGT7 data layer compared with 26 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher GGT7 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated GGT7 expression acts as an unfavorable survival marker.

HNSC, LUAD, and UCEC are the cancer types where GGT7 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Quartile	II,III,IV	0.619	0.894	.003	27	view →
LUAD	DFS	Quartile	All	0.855	0.996	.011	6	view →
UCEC	DFS	Quartile	II,III,IV	0.613	1.000	.038	6	view →
PDAC	DFS	Median	All	0.693	0.813	.017	5	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

GGT7–HNSC (DFS)

Open the HNSC breakdown →